@ARTICLE{10.3389/fonc.2020.01457, AUTHOR={Mangalaparthi, Kiran K. and Patel, Krishna and Khan, Aafaque A. and Manoharan, Malini and Karunakaran, Coral and Murugan, Sakthivel and Gupta, Ravi and Gupta, Rohit and Khanna-Gupta, Arati and Chaudhuri, Amitabha and Kumar, Prashant and Nair, Bipin and Kumar, Rekha V. and Prasad, T. S. Keshava and Chatterjee, Aditi and Pandey, Akhilesh and Gowda, Harsha}, TITLE={Mutational Landscape of Esophageal Squamous Cell Carcinoma in an Indian Cohort}, JOURNAL={Frontiers in Oncology}, VOLUME={10}, YEAR={2020}, URL={https://www.frontiersin.org/articles/10.3389/fonc.2020.01457}, DOI={10.3389/fonc.2020.01457}, ISSN={2234-943X}, ABSTRACT={Esophageal squamous cell carcinoma (ESCC) is the most common histological subtype of esophageal cancer in India. Cigarette smoking and chewing tobacco are known risk factors associated with ESCC. However, genomic alterations associated with ESCC in India are not well-characterized. In this study, we carried out exome sequencing to characterize the mutational landscape of ESCC tumors from subjects with a varied history of tobacco usage. Whole exome sequence analysis of ESCC from an Indian cohort revealed several genes that were mutated or had copy number changes. ESCC from tobacco chewers had a higher frequency of C:G > A:T transversions and 2-fold enrichment for mutation signature 4 compared to smokers and non-users of tobacco. Genes, such as TP53, CSMD3, SYNE1, PIK3CA, and NOTCH1 were found to be frequently mutated in Indian cohort. Mutually exclusive mutation patterns were observed in PIK3CA–NOTCH1, DNAH5–ZFHX4, MUC16–FAT1, and ZFHX4–NOTCH1 gene pairs. Recurrent amplifications were observed in 3q22-3q29, 11q13.3-q13.4, 7q22.1-q31.1, and 8q24 regions. Approximately 53% of tumors had genomic alterations in PIK3CA making this pathway a promising candidate for targeted therapy. In conclusion, we observe enrichment of mutation signature 4 in ESCC tumors from patients with a history of tobacco chewing. This is likely due to direct exposure of esophagus to tobacco carcinogens when it is chewed and swallowed. Genomic alterations were frequently observed in PIK3CA-AKT pathway members independent of the history of tobacco usage. PIK3CA pathway can be potentially targeted in ESCC which currently has no effective targeted therapeutic options.} }